Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium in FAP
NCT05402891Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Jun 2022
- Primary completion
- Sep 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate in familial adenomatous polyposis (FAP), sponsored by University of Amsterdam. Started Jun 2022; status: completed.
02
Drugs
lithium carbonate
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT05402891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05402891.